Harvard Ave Acquisition Corporation Unit
NASDAQ:HAVAUShell Companies
-$0.00 today
- Market cap
- $153.15M
- Beta
- 0.03
- P/E (TTM)
- 194.6
- EPS (TTM)
- $0.05
Volume 0.00M
Average 0.00M
HAVAU Total Current Assets
All assets expected to be converted to cash or used up within one year.
Harvard Ave Acquisition Corporation UnitNASDAQ: HAVAU
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets rises 11661.7% from a year ago
Total current assets stood at $993.4K at the end of Q1 FY2026, up 11661.7% from a year earlier and down 10.4% from the prior quarter.
Context
- Total current assets amounted to 0.7% of total assets at the end of Q1 FY2026, down 2.3 pp from a year earlier.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +11661.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 1.11M USD
- Year-over-year change
- +11246.8%
- 1-year CAGR
- +11246.8%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.11M | +11246.8% |
| FY2024 | 2024-12-31 | 9.78K | — |
Total Current Assets vs competitors
How HAVAU compares with its peers on the latest reported figures
- HAVAU's Mar 2026 total current assets of $993.4K is the 4th highest of the 7 companies compared; the peer median is $761.47K.
- Its year-over-year change of +11661.7% is the 2nd highest of 6, against a peer median of +5.8%.
- Total current assets amounts to 0.7% of total assets for HAVAU, versus a peer median of 0.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $69.94M | +5.8% | — | 13.1% | |
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary Shares | Mar 2026 | $2.94M | +11665.5% | — | 1.2% |
BSAABEST SPAC I Acquisition Corp. | Mar 2026 | $1.32M | — | — | 2.3% |
HAVAUHarvard Ave Acquisition Corporation Unit | Mar 2026 | $993.4K | +11661.7% | — | 0.7% |
EURKEureka Acquisition Corp Class A Ordinary Share | Mar 2026 | $202.99K | -53.1% | — | 0.6% |
| Mar 2026 | $21.54K | -96.4% | — | 0.1% | |
AFJKAimei Health Technology Co., Ltd | Mar 2026 | $18.71K | +133.2% | — | 0.2% |
| Peer median (excluding HAVAU) | $761.47K | +5.8% | — | 0.9% | |
Competitors are the stored peer set for HAVAU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 6.08K | 0 |
| Short-term Investments | 0 | 0 |
| Net Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Other Current Assets | 0 | 1.11M |
| Total Current Assets | 9.78K | 1.11M |
| Property, Plant & Equipment (Net) | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-term Investments | 0 | 146M |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 207.04K | 0 |
| Total Non-current Assets | 207.04K | 146M |
| Total Assets | 216.82K | 147.11M |
| Account Payables | 0 | 0 |
| Short-term Debt | 132.72K | 0 |
| Tax Payables | 0 | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | 0 | 473.94K |
| Total Current Liabilities | 276.54K | 473.94K |
| Long-term Debt | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 |
| Other Non-current Liabilities | 0 | 4.35M |
| Total Non-current Liabilities | 0 | 4.35M |
| Total Liabilities | 276.54K | 4.82M |
| Common Stock | 690 | 146M |
| Retained Earnings | (84.72K) | (3.72M) |
| Accumulated OCI | 0 | 0 |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 0 | 0 |
| Total Equity | (59.72K) | (3.71M) |
| Total Debt | 132.72K | 0 |
| Net Debt | 126.64K | 0 |
Harvard Ave Acquisition Corporation Unit
NASDAQ:HAVAU
Intrinsic Alpha fair value
Locked
Current Price
$10.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.